Nu Skin Enterprises reported fourth quarter and full-year 2025 financial results within guidance, with Q4 revenue of $370.3 million and full-year revenue of $1.49 billion, and provided initial outlook for Q1 and fiscal year 2026 forecasting a return to revenue growth by year's end.
Key takeaways
Q4 2025 revenue was $370.3 million, a 16.9% decrease from the prior-year quarter, with a 0.2% negative foreign currency impact.
Full-year 2025 revenue was $1.49 billion, a 14.3% decrease from 2024, with a 0.8% negative foreign currency impact.
Q4 2025 diluted EPS was $0.29 compared to $(0.73) in the prior-year quarter; full-year 2025 EPS was $3.18 compared to $(2.95) in 2024.
The company provided Q1 2026 revenue guidance of $320 to $340 million and EPS guidance of $0.10 to $0.20, and full-year 2026 revenue guidance of $1.35 to $1.50 billion and EPS guidance of $0.80 to $1.20.
The company repurchased $10.0 million of stock during Q4 2025 and has $142.3 million remaining in its authorization.
The company is launching the Prysm iO intelligent wellness platform globally and preparing for market entry in India in the second half of 2026.